Elham Delrish
Overview
Explore the profile of Elham Delrish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delrish E, Jabbarvand M, Ghassemi F, Amoli F, Atyabi F, Heidari Keshel S, et al.
J Ophthalmic Vis Res
. 2023 Mar;
18(1):68-80.
PMID: 36937194
Purpose: This research intended to fabricate the thiolated chitosan-dextran nanoparticles (NPs) containing topotecan (TPH-CMD-TCS-NPs) to assess the ability of NPs in improving the efficacy of intravitreal chemotherapy of retinoblastoma in...
2.
Delrish E, Ghassemi F, Jabbarvand M, Lashay A, Atyabi F, Soleimani M, et al.
J Ophthalmic Vis Res
. 2022 Jun;
17(2):158-159.
PMID: 35765626
[This corrects the article DOI: 10.18502/jovr.v17i1.10171.].
3.
Delrish E, Ghassemi F, Jabbarvand M, Lashay A, Atyabi F, Soleimani M, et al.
J Ophthalmic Vis Res
. 2022 Feb;
17(1):58-68.
PMID: 35194497
Purpose: The use of more potent medicine for local chemotherapy of retinoblastoma in order to minimize local and systemic adverse effects is essential. The main goal of this investigation was...
4.
Delrish E, Jabbarvand M, Ghassemi F, Amoli F, Atyabi F, Lashay A, et al.
Exp Eye Res
. 2021 Jan;
204:108423.
PMID: 33453276
Retinoblastoma (Rb) is the most common intraocular malignancy in children that accounts for approximately 4% of all pediatric malignancies. Since chemotherapy is a widely practiced treatment for Rb, there is...
5.
Lashay A, Faghihi H, Mirshahi A, Khojasteh H, Khodabande A, Riazi-Esfahani H, et al.
J Ophthalmic Vis Res
. 2020 Sep;
15(3):341-350.
PMID: 32864065
Purpose: To evaluate the safety of intravitreal injection of Stivant, a biosimilar to bevacizumab, in rabbits using electrophysiological and histological analysis. Methods: Both eyes of 41 New Zealand albino rabbits...
6.
Lashay A, Riazi-Esfahani H, Faghihi H, Mirshahi A, Khojasteh H, Khodabande A, et al.
J Ophthalmol
. 2020 Jul;
2020:2602918.
PMID: 32714608
Purpose: To assess the safety of biosimilar intravitreal aflibercept (CinnaGen Co., Iran) compared to the reference product (Eylea®; Bayer Schweiz AG, Zurich, Switzerland) in rabbit eyes through functional and histologic...
7.
Lashay A, Delrish E, Ashrafi E, Movassat M, Asadi-Amoli F, Dinarvand R, et al.
Ophthalmic Surg Lasers Imaging Retina
. 2019 Dec;
50(12):785-790.
PMID: 31877224
Background And Objective: To evaluate the safety and bioavailability of complete and half-dose of intravitreal ziv-aflibercept (IVZ) in an experimental model. Materials And Methods: Thirty-two eyes of 16 male rabbits...
8.
Khoshzaban A, Keyhanvar P, Delrish E, Najafi F, Heidari Keshel S, Watanabe I, et al.
Cell J
. 2018 Jan;
20(1):25-30.
PMID: 29308615
Objectives: Alginate, known as a group of anionic polysaccharides extracted from seaweeds, has attracted the attention of researchers because of its biocompatibility and degradability properties. Alginate has shown beneficial effects...
9.
Tahvildari K, Anaraki Y, Fazaeli R, Mirpanji S, Delrish E
J Environ Health Sci Eng
. 2015 Oct;
13:73.
PMID: 26500782
Background: Fossil fuels' pollution and their non-renewability have motivated the search for alternative fuels. Some common example of seed oils are sunflower oil, date seed oil, soy bean oil. For...
10.
Mohammadpour M, Jabbarvand M, Hashemi H, Delrish E
Adv Biomed Res
. 2015 Aug;
4:124.
PMID: 26261826
Background: Angiogenesis-related corneal blindness includes the spectrum of corneal diseases that are caused by pathological angiogenesis, leading to untoward visual impairment. The purpose of this study was to investigate the...